Skip to main navigation Skip to search Skip to main content

A phase 2 randomized, double-blind, placebo-controlled trial of MHAA4549A, a monoclonal antibody, plus oseltamivir in patients hospitalized with severe influenza a virus infection

  • Jeremy J. Lim
  • , Anna C. Nilsson
  • , Michael Silverman
  • , Nimer Assy
  • , Priya Kulkarni
  • , Jacqueline M. McBride
  • , Rong Deng
  • , Chloe Li
  • , Xiaoying Yang
  • , Allen Nguyen
  • , Priscilla Horn
  • , Mauricio Maia
  • , Aide Castro
  • , Melicent C. Peck
  • , Joshua Galanter
  • , Tom Chu
  • , Elizabeth M. Newton
  • , Jorge A. Tavel

Research output: Contribution to journal › Article › peer-review

35 Scopus citations

Fingerprint

Dive into the research topics of 'A phase 2 randomized, double-blind, placebo-controlled trial of MHAA4549A, a monoclonal antibody, plus oseltamivir in patients hospitalized with severe influenza a virus infection'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology